Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pyrus is an early-stage healthtech and medical device company developing virtual, augmented, and mixed reality tools for surgical planning and procedural navigation, with an initial focus on cardiac electrophysiology and arrhythmia care. The company emerged from the University of Washington ecosystem and was launched in 2017. Its best-described product program is CathEye, a market-ready or full-product-ready visualization and navigation tool intended to support cardiac ablation workflows and improve understanding of patient-specific anatomy. Pyrus has also described broader software offerings for interactive 3D surgical planning and medical education. Overall, the company appears to be a small private medtech startup rather than a therapeutics biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pyrus.